So Many Terms, So Much to Learn …
Editorial by Bruce Shriver, PhD
Drs. Rutkowski and Switaj discuss why Imatinib is currently the gold standard therapy of inoperable, metastatic, or recurrent cases of DFSP.
Targeting Bone Microenvironment as a New Therapeutic Strategy in Ewing’s Sarcoma: Combination of Zoledronic Acid with Chemotherapy in Mouse Preclinical Models
In this experimental plan, Drs. Odri, Corradini, and Rédini describe their studies, the impact of which may be to propose zoledronic acid as adjuvant therapy in Ewing sarcoma patients for the next European protocol.
Somatic Mutation Profiling of PI3K Pathway in Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumors
In this experimental plan, Drs. Clarke, Hale, Gilks, and Boutros describe a study in which they will analyze the mutation profile of the genes involved in the PI3K pathway in an annotated cohort of uterine carcinosarcomas.
The Liddy Shriver Sarcoma Initiative has awarded a $90,000 grant for Ewing's sarcoma research at the University of Nantes in France.
The Liddy Shriver Sarcoma Initiative has awarded $50,000 for an international collaborative study on carcinosarcomas.